Lung Cancer

Nasal Swab Test Can Improve Early Lung Cancer Assessment

Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.

Lung Cancer

BioAffinity Automated Flow Cytometry Test Detects Lung Cancer in Sputum

The test validation trial resulted in CyPath Lung specificity of 88% and sensitivity of 82%, similar to far more invasive procedures currently used to diagnose lung cancer.

Lung Cancer

Israel Expands Non-Small Cell Lung Cancer Testing Coverage

Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.

Study Offers Promise for Multicancer Detection from a Single Blood Draw

Apr 6, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.

Targeted Cancer Medicine Offers Hope for Neuroblastoma Treatment

Jan 27, 2020 | Lung Cancer

Targeted cancer treatment using an ALK inhibitor in combination with a PIM1 inhibitor can increase the chances of survival of children with an unfavorable prognosis.

T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer

Jan 10, 2020 | Breast, Lung Cancer, Sepsis

T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.

AI Modeling Drives Genomic Profiling Similarity Score

Dec 31, 2019 | Lung Cancer

Caris Life Sciences’ Molecular Intelligence GPS score aids in the characterization of cancer of unknown primary and atypical cases, while also identifying appropriate treatment options.

Blood Specimen Collection Device

Nov 19, 2019 | Containers, Lung Cancer, Tubes

Innovative device enhances ease of use and reduces the costs and environmental impact of blood sample collection, processing, and shipping.

Trial Demonstrates Potential of Blood Test to Reduce Late Detection of Lung Cancer

Oct 15, 2019 | Immunoassay, Lung Cancer

The Early Detection for Cancer of the Lung Scotland trial is believed to be the world’s largest trial for the detection of lung cancer using biomarkers.

Veracyte Introduces Percepta Genomic Sequencing Classifier

Aug 26, 2019 | Culture Media, Lung Cancer, Molecular Diagnostics

The new genomic test is Veracyte’s first commercial product since the company signed a strategic collaboration with Johnson & Johnson Innovation.

Economic Study Reveals Ways to Improve the Cost-Benefit of Multigene Panel Sequencing for Advanced Non-Small Cell Lung Cancer

Aug 26, 2019 | Lung Cancer

Multigene panels would deliver greater value if patients with actionable genetic mutations consistently received guided treatments.

Liquid Biopsies Guide Improved Cancer Treatment

Aug 26, 2019 | Breast, Cytology, Histology, Leukemia, Lung Cancer, Melanoma, Molecular Diagnostics, Prostate

Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.

Saga Raises $4.1 Million to Advance Ultrasensitive Liquid Biopsies

Aug 7, 2019 | Breast, Leukemia, Lung Cancer, Molecular Diagnostics

The funds will be used to accelerate commercialization of Saga’s portfolio of kits and services, continue development of new products, and perform prospective clinical studies.

Immunohistochemistry Test Detects ROS1 Protein in Cancer

Jul 23, 2019 | Lung Cancer, Lymphoma, Unknown Origin & Other Cancer Types

The biomarker may provide a cost-effective and efficient means to identify elevated ROS1 protein expression in cancer.

Genetic Cancer Test Granted FDA Breakthrough Device Designation

Jun 30, 2019 | Breast, Lung Cancer

The designation’s accelerated regulatory review is intended to expedite use of the diagnostic in pharmaceutical trials.

Decision Expands Guardant360 Coverage to Most Solid Tumor Types

Apr 30, 2019 | Lung Cancer

The draft LCD applies to advanced cancer patients who are covered by Medicare for next-generation sequencing of tumor tissue, but have insufficient or unavailable tissue samples.

Mayo Clinic Announces Collaboration to Develop Diagnostic for Lung Cancer

Apr 18, 2019 | Lung Cancer

The tests will use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.

MRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostic

Jan 31, 2019 | Lung Cancer

The companies’ collaboration underscores the need for proteomic data to enable precision medicine strategies for lung cancer patients.

Category: Lung Cancer

Lung Cancer

Lung Cancer

Lung Cancer